Velbe
Brand names,
Velbe
Analogs
Velbe
Brand Names Mixture
Velbe
Chemical_Formula
C46H58N4O9
Velbe
RX_link
http://www.rxlist.com/cgi/generic3/vinblastine.htm
Velbe
fda sheet
Velbe
msds (material safety sheet)
Velbe
Synthesis Reference
No information avaliable
Velbe
Molecular Weight
810.974 g/mol
Velbe
Melting Point
267 oC
Velbe
H2O Solubility
Negligible
Velbe
State
Solid
Velbe
LogP
5.587
Velbe
Dosage Forms
Liquid; Powder for solution; Solution
Velbe
Indication
For treatment of breast cancer, testicular cancer, lymphomas, neuroblastoma, Hodgkin's and non-Hodgkin's lymphomas, mycosis fungoides, histiocytosis, and Kaposi's sarcoma.
Velbe
Pharmacology
Vinblastine is a vinca alkaloid antineoplastic agent. The vinca alkaloids are structurally similar compounds comprised of 2 multiringed units: vindoline and catharanthine. The vinca alkaloids have become clinically useful since the discovery of their antitumour properties in 1959. Initially, extracts of the periwinkle plant (Catharanthus roseus) were investigated because of putative hypoglycemic properties, but were noted to cause marrow suppression in rats and antileukemic effects in vitro. Vinblastine has some immunosuppressant effect. The vinca alkaloids are considered to be cell cycle phase-specific.
Velbe
Absorption
No information avaliable
Velbe
side effects and Toxicity
Oral, mouse: LD50 = 423 mg/kg; Oral, rat: LD50 = 305 mg/kg.
Velbe
Patient Information
Velbe
Organisms Affected
Humans and other mammals